share_log

Inhibikase Therapeutics To Be Granted U.S. Patent Titled 'COMPOSITIONS AND METHODS FOR INHIBITING KINASES (FOR PREVENTION/TREATMENT OF CANCER OR BACTERIAL/VIRAL INFECTION)'

Benzinga Real-time News ·  Aug 8, 2022 12:14
Inhibikase Therapeutics To Be Granted U.S. Patent Titled 'COMPOSITIONS AND METHODS FOR INHIBITING KINASES (FOR PREVENTION/TREATMENT OF CANCER OR BACTERIAL/VIRAL INFECTION)'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment